Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
clinical trials
fda
life sciences
national blog main
acute hepatic porphyrias
akin akinc
alder biopharmaceuticals
alnylam pharmaceuticals
amgen
aminolevulinic acid
biotech
boston
boulder/denver blog main
boulder/denver top stories
calcitonin gene-related peptide
chronic migraine
david rind
detroit blog main
detroit top stories
drugs
eli lilly
episodic migraine
eptinezumab
erenumab
food and drug administration
fremanezumab
galcanezumab
givosiran
indiana blog main
indiana top stories
institute for clinical and economic review
migraine research foundation
migraines
national
national top stories
new york blog main
new york top stories
novartis
What
approval
2
×
drug
fda
2
×
nod
2
×
ago
alnylam
amgen
candidates
class
developed
gets
head
indicated
interference
medicine
medicines
migraine
new
pain
pharmaceuticals
preventive
quick
rna
rnai
second
seek
speedy
starts
weeks
won
won’t
Language
Current search:
nod
×
fda
×
approval
×
@xconomy.com
5 years ago
Alnylam Won’t Seek Quick FDA Nod For Second RNAi Drug
@xconomy.com
5 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines